Davoudian K, Spagnolo S, Chan E, Hianik T, Thompson M
Sensors (Basel). 2025; 24(24.
PMID: 39771624
PMC: 11678973.
DOI: 10.3390/s24247884.
Zeng S, Wang X, Yang H
Mil Med Res. 2024; 11(1):77.
PMID: 39673071
PMC: 11645790.
DOI: 10.1186/s40779-024-00580-1.
Abbas S, Asif M, Rehman A, Alharbi M, Khan M, Elmitwally N
Heliyon. 2024; 10(17):e36743.
PMID: 39263113
PMC: 11387343.
DOI: 10.1016/j.heliyon.2024.e36743.
Liu Y, Zhang Q, Zhang F, Liu M, Zhang J, Cao X
Front Oncol. 2024; 14:1404426.
PMID: 39040447
PMC: 11260635.
DOI: 10.3389/fonc.2024.1404426.
Ilieva-Gabarska P, Racheva V
Balkan Med J. 2024; 41(4):314-316.
PMID: 38470308
PMC: 11588893.
DOI: 10.4274/balkanmedj.galenos.2024.2023-12-84.
Staging by imaging in gynecologic cancer and the role of ultrasound: an update of European joint consensus statements.
Fischerova D, Smet C, Scovazzi U, Sousa D, Hundarova K, Haldorsen I
Int J Gynecol Cancer. 2024; 34(3):363-378.
PMID: 38438175
PMC: 10958454.
DOI: 10.1136/ijgc-2023-004609.
Artificial Intelligence in Ultrasound Diagnoses of Ovarian Cancer: A Systematic Review and Meta-Analysis.
Mitchell S, Nikolopoulos M, El-Zarka A, Al-Karawi D, Al-Zaidi S, Ghai A
Cancers (Basel). 2024; 16(2).
PMID: 38275863
PMC: 10813993.
DOI: 10.3390/cancers16020422.
Application of medical imaging in ovarian cancer: a bibliometric analysis from 2000 to 2022.
Leng Y, Li S, Zhu J, Wang X, Luo F, Wang Y
Front Oncol. 2023; 13:1326297.
PMID: 38111527
PMC: 10725957.
DOI: 10.3389/fonc.2023.1326297.
Coupled Electrostatic and Hydrophobic Destabilisation of the Gelsolin-Actin Complex Enables Facile Detection of Ovarian Cancer Biomarker Lysophosphatidic Acid.
Davoudian K, Bhattacharya S, Thompson D, Thompson M
Biomolecules. 2023; 13(9).
PMID: 37759826
PMC: 10527313.
DOI: 10.3390/biom13091426.
Photoacoustic clinical applications: Musculoskeletal and abdominal imaging.
Ni L, Wang X, Xu G
Z Med Phys. 2023; 33(3):324-335.
PMID: 37365088
PMC: 10517401.
DOI: 10.1016/j.zemedi.2023.04.009.
Development of a dual energy CT based model to assess response to treatment in patients with high grade serous ovarian cancer: a pilot cohort study.
Alizzi Z, Gogbashian A, Karteris E, Hall M
Cancer Imaging. 2023; 23(1):62.
PMID: 37322564
PMC: 10268407.
DOI: 10.1186/s40644-023-00579-2.
Prediction of Surgical Outcome in Advanced Ovarian Cancer by Imaging and Laparoscopy: A Narrative Review.
Pinto P, Burgetova A, Cibula D, Haldorsen I, Indrielle-Kelly T, Fischerova D
Cancers (Basel). 2023; 15(6).
PMID: 36980790
PMC: 10047411.
DOI: 10.3390/cancers15061904.
A Nomogram for Preoperative Prediction of the Risk of Lymph Node Metastasis in Patients with Epithelial Ovarian Cancer.
Xiang H, Yang F, Zheng X, Pan B, Ju M, Xu S
Curr Oncol. 2023; 30(3):3289-3300.
PMID: 36975463
PMC: 10047242.
DOI: 10.3390/curroncol30030250.
Preoperative prediction of miliary changes in the small bowel mesentery in advanced high-grade serous ovarian cancer using MRI radiomics nomogram.
Guo Q, Lin Z, Lu J, Li R, Wu L, Deng L
Abdom Radiol (NY). 2023; 48(3):1119-1130.
PMID: 36651979
DOI: 10.1007/s00261-023-03802-7.
A Machine Learning Approach Using XGBoost Predicts Lung Metastasis in Patients with Ovarian Cancer.
Yuan Y, Wang R, Luo M, Zhang Y, Guo F, Bai G
Biomed Res Int. 2022; 2022:8501819.
PMID: 36277898
PMC: 9581702.
DOI: 10.1155/2022/8501819.
The role of computed tomography in the assessment of tumour extent and the risk of residual disease after upfront surgery in advanced ovarian cancer (AOC).
Asp M, Malander S, Wallengren N, Pudaric S, Bengtsson J, Sartor H
Arch Gynecol Obstet. 2022; 306(4):1235-1243.
PMID: 35235024
PMC: 9470643.
DOI: 10.1007/s00404-022-06466-8.
The Development and Validation of a CT-Based Radiomics Nomogram to Preoperatively Predict Lymph Node Metastasis in High-Grade Serous Ovarian Cancer.
Chen H, Wang X, Zhao F, Chen X, Li X, Ning G
Front Oncol. 2021; 11:711648.
PMID: 34532289
PMC: 8438232.
DOI: 10.3389/fonc.2021.711648.
Preoperative Prediction of Metastasis for Ovarian Cancer Based on Computed Tomography Radiomics Features and Clinical Factors.
Ai Y, Zhang J, Jin J, Zhang J, Zhu H, Jin X
Front Oncol. 2021; 11:610742.
PMID: 34178617
PMC: 8222738.
DOI: 10.3389/fonc.2021.610742.
A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer (Review).
Falzone L, Scandurra G, Lombardo V, Gattuso G, Lavoro A, Distefano A
Int J Oncol. 2021; 59(1).
PMID: 34132354
PMC: 8208622.
DOI: 10.3892/ijo.2021.5233.
Preoperative Nomogram for Differentiation of Histological Subtypes in Ovarian Cancer Based on Computer Tomography Radiomics.
Zhu H, Ai Y, Zhang J, Zhang J, Jin J, Xie C
Front Oncol. 2021; 11:642892.
PMID: 33842352
PMC: 8027335.
DOI: 10.3389/fonc.2021.642892.